Mouse B1 B cells originate in the embryonic liver and are the major B-cell population in the peritoneal and pleural cavities.
Mouse B1 B cells originate in the embryonic liver and are the major B-cell population in the peritoneal and pleural cavities. [1] [2] [3] [4] [5] By contrast, mouse B2 B cells originate in the bone marrow and are the major B-cell population in the bone marrow, spleen, and blood. B1 and B2 B cells differ not only in their origin and locations, but also in their antigen specificity, cell surface markers, capacities for class-switch recombination (CSR) and somatic hypermutation (SHM). IgH cis-regulatory regions and, particularly, transcriptional super-enhancers are major locus regulators under both normal and pathological conditions. 6, 7 Important differences have been found regarding the ability of the IgH 3′ regulatory region (3′RR) super-enhancer to control the B1 and B2 B-cell fate. 8, 9 Thus, the 3′RR super-enhancer controls the IgA CSR in B2 B cells, 10, 11 but not in B1 B cells. 12 On the other hand, the 3′RR super-enhancer controls the late VDJ repertoire diversity in B1 B cells, 9 but not in B2 B cells. 13, 14 Taken together, these data indicate similarities and differences in the 3′RR control of B1 and B2 B-cell maturation. Similar to CSR, SHM requires activation-induced cytidine deaminase (AID) activity. 15 While AID targets the switch region during CSR, generating double-strand DNA breaks to change the Ig heavy-chain isotype for new effector functions, the enzyme targets VDJ regions during SHM to improve the Ig affinity for antigens. 15 Previous studies have highlighted the role of the 3′ RR super-enhancer as the master control element of SHM in B2 B cells. 16, 17 We thus investigated whether the 3′RR super-enhancer also controls SHM in B1 B cells.
Our research was approved by our local ethics committee review board (Comité Régional d'Ethique sur l'Expérimentation Animale du Limousin, Limoges, France) and carried out according to the European guidelines for animal experimentation. The disruption of the 3′RR was carried out in the Sv/129 embryonic stem cell line. 10 Mice were bred and maintained under specific pathogen-free conditions. Sv/129 wt mice were used as control mice. AID-deficient mice were used as a negative control (to correct for baseline noise due to PCR errors and mutations in the VDJ segment, induced during the generation of the VDJ repertoire). B1 B cells were isolated from the peritoneal cavity of mice immunized orally with sheep red blood cells for 2 weeks and intraperitoneally with 10 μg of LPS (Invivogen, Toulouse, France) for 3 days. B1 B cells were sorted using a BD FACSAria III sorter (BD Biosciences, Franklin Lakes, NJ) (Flow cytometry and cell sorting platform of the University of Limoges, France). The following antibodies were used: anti-B220-BV510 (Biolegend, San Diego, CA), anti-CD23-PC (Biolegens) 7, anti-IgM-FITC (eBioscience, San Diego CA), anti-CD11b-eF780 (eBioscience), anti-IgD-BV421 (Biolegend), and anti-CD19-PE (Biolegend RNA was extracted from sorted B1 B cells, and 250 ng of RNA was used for sequencing. Transcripts were amplified by 5′ Rapid Amplification of cDNA-ends by polymerase chain reaction (5'RACE PCR) using a reverse primer hybridizing within the µ C H1 exon as described. 18 Sequencing adapter sequences were thus added by primer extension, and resulting amplicons were sequenced on a MiSeq system (Illumina, Evry, France). Sequence analysis was performed using the IMGT/High-V-Quest 19 and R programs. B1 B cells are the major B-cell population in the pleural and peritoneal cavities, but are rarely detected in lymph nodes and the spleen and almost undetectable in the bone marrow. We thus sorted B1 B cells from the mouse peritoneal cavity (Fig. 1a) . B1 B cells were reported to accumulate SHMs in V H regions (albeit at a lower frequency than B2 B cells do). 20 Investigation in the 3′RR-deficient mice showed that the levels of SHM in B1 B-cell V H regions were significantly (p = 0.008, t-test with Welch's correction) reduced, by 38% compared with those in B1 B cells from the wt mice (Fig. 1b, left  part) . The numbers of investigated sequences and mutations are presented in the right part of Fig. 1b . The proportions of mutations at the A, T, G, and C nucleotides in the 3′RR-deficient and wt mice are shown in Fig. 1c . AID-deficient mice are an appropriate control for the baseline values of mutations in the V H region. As shown in Fig. 1b , the number of mutations in the 3′RR-deficient mice was not reduced relative to the baseline level found in the AID-deficient mice (9094 analyzed sequences for these mice), highlighting the presence of remaining SHM in B1 B-cell V H regions of the 3′RR-deficient mice. Finally, no difference was found when investigating fetal liver B1 B cells (Fig. 1d, left part) from the 3′RR-deficient and wt mice, strengthening the hypothesis that deletion of the 3′RR superenhancer (known to act at the mature B-cell stage) 21 reduces the SHM process only in mature B1 B cells. The numbers of investigated sequences and mutations are presented in the right part of Fig. 1d . Interestingly, our results show an increased number of N nucleotides added during VDJ recombination in B1 B cells of the 3′RR-deficient mice and even more in the AID-deficient mice (Fig. 1e) . Although not statistically significant, this increase appears to be inversely correlated with the SHM frequency and can reflect the existence of a mechanism of compensation for the lack of diversity due to the lack of AID-induced mutations. We have previously shown that the 3′RR deficiency does not affect the repertoire generation in immature B cells; 9, 13 therefore, this difference between the wt mice and 3′RR-deficient and AID-deficient mice more likely reveals a biased antigen-dependent selection. This hypothesis is strengthened by the strongly decreased amounts of N nucleotides in fetal liver B1 B cells from both wt and 3′RR-deficient mice, which are generated before any antigen-dependent selection.
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During evolution, Ig synthesis was followed by SHM and CSR. 22, 23 While both SHM and CSR require specific and precise AID targeting, mechanistic differences in the control of AID recruitment and AID-induced DNA breaks have been demonstrated between these two processes. 24 The results of the present study indicate that similar to B2 B cells, 16 deletion of the 3′RR superenhancer reduces SHM in B1 B cells. The evolution of the immune system involves an overlap between innate and adaptive immunity. B1 B cells represent an early B-cell lineage, whereas B2 B cells appear to have arisen later in evolution. The 3′RR controls the IgH transcription and SHM in both B1 and B2 B cells, 8, 9 but CSR (except that in IgD) 25, 25 is only controlled by the super-enhancer in specialized B2 B cells, 11, 12, 16 confirming its involvement in adaptive immunity, and showing the segregation in the mechanisms of CSR and SHM between B1 and B2 B cells during evolution. 
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-B1 B-cell population. b Left part: mutation frequencies (per 100 bp) in the V H regions of B1 B cells from the peritoneal cavity of 3′RR-deficient mice, AID-deficient mice, and wt mice. B1 B cells were pooled from nine wt mice, nine 3′RR-deficient mice, and nine AID-deficient mice. One experiment for AIDdeficient mice and two independent experiments for wt mice and 3′RR-deficient mice each were performed. Right part: numbers of sequences and mutations for 3′RR-deficient and wt mice. c Mutation frequencies at the A, T, C, and G nucleotides for 3′RR-deficient and wt mice. d Left part: mutation frequencies in V H regions of fetal (12 h before birth) liver B1 B cells of 3′RR-deficient and wt mice. Cells were pooled from six fetuses of 3′RR-deficient mice and six fetuses of wt mice. B220
+ cells were cell-sorted for these experiments. Right part: numbers of sequences and mutations for 3′RR-deficient and wt mice. e The mean number of N nucleotides added in each B1 B-cell clone sequence during VDJ recombination. B1 B cells were pooled from nine wt mice, nine 3′RR-deficient mice, and nine AID-deficient mice. Fetal B1 B cells were pooled from six fetuses of 3′RR-deficient mice and six fetuses of wt mice
